The JI
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     
 


This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow Request Permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Pérez de la Lastra, J. M.
Right arrow Articles by Morgan, B. P.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Pérez de la Lastra, J. M.
Right arrow Articles by Morgan, B. P.
The Journal of Immunology, 00, 165: 2563-2573.
Copyright © 00 by The American Association of Immunologists

Pigs Express Multiple Forms of Decay-Accelerating Factor (CD55), All of Which Contain Only Three Short Consensus Repeats1

J. M. Pérez de la Lastra, C. L. Harris, S. J. Hinchliffe, D. S. Holt, N. K. Rushmere and B. Paul Morgan2

Complement Biology Group, Department of Medical Biochemistry, University of Wales College of Medicine, Heath Park, Cardiff, United Kingdom

We report the cloning of cDNAs encoding multiple isoforms of the pig analogue of human decay-accelerating factor (DAF; CD55). Screening of a pig muscle cDNA library using a human DAF probe identified a single clone that encoded a DAF-like molecule comprising three short consensus repeats (SCR) homologous with the amino-terminal three SCR in human DAF, a serine/threonine-rich (ST) region, and sequence compatible with a transmembrane domain and cytoplasmic tail. Northern blot and RT-PCR analysis showed that pig DAF was expressed in a wide range of tissues. Additional isoforms of DAF were sought using RT-PCR and 3'-rapid amplification of cDNA ends followed by sequencing. Isoforms containing a GPI anchor and with differing lengths of ST region were identified; no isoform containing a fourth SCR was found. Cloning of the GPI-anchored isoform from granulocytes confirmed that it was identical with the original transmembrane isoform through the three SCR and first portion of ST and was derived from a frame shift caused by splicing out 176 bp of sequence. A panel of mAbs was generated and used to analyze the distribution and anchoring of pig DAF in circulating cells. Pig DAF was expressed on all circulating cells and was transmembrane anchored on erythrocytes, but completely or partially GPI anchored on granulocytes and mononuclear cells. The transmembrane isoform of pig DAF was expressed on Chinese hamster ovary cells and was shown to affect regulatory activity for the classical pathway of human complement, but was only marginally active against pig serum.




This article has been cited by other articles:


Home page
J BiochemHome page
C. Kobayashi, K. Matsunami, T. Omori, S. Nakatsu, K. Nakahata, H. Xu, R. Shirakura, M. Fukuzawa, and S. Miyagawa
Features of a Newly Cloned Pig C1 Esterase Inhibitor
J. Biochem., September 1, 2006; 140(3): 421 - 427.
[Abstract] [Full Text] [PDF]


Home page
J. Gen. Virol.Home page
M. A. Jimenez-Clavero, E. Escribano-Romero, V. Ley, and O. B. Spiller
More recent swine vesicular disease virus isolates retain binding to coxsackie-adenovirus receptor, but have lost the ability to bind human decay-accelerating factor (CD55)
J. Gen. Virol., May 1, 2005; 86(5): 1369 - 1377.
[Abstract] [Full Text] [PDF]


Home page
Biol. Reprod.Home page
J. M. Dufour, M. Hamilton, R. V. Rajotte, and G. S. Korbutt
Neonatal Porcine Sertoli Cells Inhibit Human Natural Antibody-Mediated Lysis
Biol Reprod, May 1, 2005; 72(5): 1224 - 1231.
[Abstract] [Full Text] [PDF]


Home page
J. Immunol.Home page
J. van Beek, M. van Meurs, B. A. 't Hart, H. P. M. Brok, J. W. Neal, A. Chatagner, C. L. Harris, N. Omidvar, B. P. Morgan, J. D. Laman, et al.
Decay-Accelerating Factor (CD55) Is Expressed by Neurons in Response to Chronic but Not Acute Autoimmune Central Nervous System Inflammation Associated with Complement Activation
J. Immunol., February 15, 2005; 174(4): 2353 - 2365.
[Abstract] [Full Text] [PDF]


Home page
Infect. Immun.Home page
S. Hudault, O. B. Spiller, B. P. Morgan, and A. L. Servin
Human Diffusely Adhering Escherichia coli Expressing Afa/Dr Adhesins That Use Human CD55 (Decay-Accelerating Factor) as a Receptor Does Not Bind the Rodent and Pig Analogues of CD55
Infect. Immun., August 1, 2004; 72(8): 4859 - 4863.
[Abstract] [Full Text] [PDF]


Home page
J. Gen. Virol.Home page
H. W. Favoreel, G. R. Van de Walle, H. J. Nauwynck, and M. B. Pensaert
Virus complement evasion strategies
J. Gen. Virol., January 1, 2003; 84(1): 1 - 15.
[Abstract] [Full Text] [PDF]


Home page
J. Gen. Virol.Home page
O. B. Spiller, I. G. Goodfellow, D. J. Evans, S. J. Hinchliffe, and B. P. Morgan
Coxsackie B viruses that use human DAF as a receptor infect pig cells via pig CAR and do not use pig DAF
J. Gen. Virol., January 1, 2002; 83(1): 45 - 52.
[Abstract] [Full Text] [PDF]


Home page
J. Immunol.Home page
L. A. Kuttner-Kondo, L. Mitchell, D. E. Hourcade, and M. E. Medof
Characterization of the Active Sites in Decay-Accelerating Factor
J. Immunol., August 15, 2001; 167(4): 2164 - 2171.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
This Website Copyright © 2000 by The American Association of Immunologists, Inc. All rights reserved.
All Contents Copyright © 2000 by The American Association of Immunologists, Inc. All rights reserved.